Compare AMBA & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMBA | CLDX |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 2011 | 1995 |
| Metric | AMBA | CLDX |
|---|---|---|
| Price | $50.42 | $30.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $97.25 | $44.50 |
| AVG Volume (30 Days) | ★ 911.2K | 818.1K |
| Earning Date | 02-26-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.32 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $295,402,000.00 | $12,743,000.00 |
| Revenue This Year | $15.69 | $111.39 |
| Revenue Next Year | $13.06 | $235.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $38.90 | $14.40 |
| 52 Week High | $96.69 | $34.52 |
| Indicator | AMBA | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 31.98 | 54.64 |
| Support Level | N/A | $28.25 |
| Resistance Level | $71.00 | $30.90 |
| Average True Range (ATR) | 2.15 | 1.52 |
| MACD | 0.17 | -0.06 |
| Stochastic Oscillator | 7.16 | 36.74 |
Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.